315 related articles for article (PubMed ID: 36005646)
1. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer.
Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y
Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Multiparametric MRI Radiomics-Based Nomogram in Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Two-Center study.
Wang X; Hua H; Han J; Zhong X; Liu J; Chen J
Clin Breast Cancer; 2023 Aug; 23(6):e331-e344. PubMed ID: 37321954
[TBL] [Abstract][Full Text] [Related]
3. Radiomics of contrast-enhanced spectral mammography for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer.
Zhang K; Lin J; Lin F; Wang Z; Zhang H; Zhang S; Mao N; Qiao G
J Xray Sci Technol; 2023; 31(4):669-683. PubMed ID: 37066960
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive prediction model of axillary lymph node status in patients with early-stage breast cancer: a feasibility study based on dynamic contrast-enhanced-MRI radiomics.
Chen W; Lin G; Kong C; Wu X; Hu Y; Chen M; Xia S; Lu C; Xu M; Ji J
Br J Radiol; 2024 Feb; 97(1154):439-450. PubMed ID: 38308028
[TBL] [Abstract][Full Text] [Related]
5. Radiomics nomogram for predicting axillary lymph node metastasis in breast cancer based on DCE-MRI: A multicenter study.
Zhang J; Zhang Z; Mao N; Zhang H; Gao J; Wang B; Ren J; Liu X; Zhang B; Dou T; Li W; Wang Y; Jia H
J Xray Sci Technol; 2023; 31(2):247-263. PubMed ID: 36744360
[TBL] [Abstract][Full Text] [Related]
6. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jiang M; Li CL; Luo XM; Chuan ZR; Lv WZ; Li X; Cui XW; Dietrich CF
Eur J Cancer; 2021 Apr; 147():95-105. PubMed ID: 33639324
[TBL] [Abstract][Full Text] [Related]
8. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Prediction of Axillary Lymph Node Metastasis in Breast Cancer Based on Intratumoral and Peritumoral DCE-MRI Radiomics Nomogram.
Liu Y; Li X; Zhu L; Zhao Z; Wang T; Zhang X; Cai B; Li L; Ma M; Ma X; Ming J
Contrast Media Mol Imaging; 2022; 2022():6729473. PubMed ID: 36051932
[TBL] [Abstract][Full Text] [Related]
10. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Chen X; Chen X; Yang J; Li Y; Fan W; Yang Z
J Comput Assist Tomogr; 2020; 44(2):275-283. PubMed ID: 32004189
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer.
Song D; Yang F; Zhang Y; Guo Y; Qu Y; Zhang X; Zhu Y; Cui S
Cancer Imaging; 2022 Apr; 22(1):17. PubMed ID: 35379339
[TBL] [Abstract][Full Text] [Related]
12. Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer.
Zeng Q; Xiong F; Liu L; Zhong L; Cai F; Zeng X
Acad Radiol; 2023 Sep; 30 Suppl 2():S38-S49. PubMed ID: 37169624
[TBL] [Abstract][Full Text] [Related]
13. Computed Tomography-Based Radiomics Analysis for Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Duan Y; Yang G; Miao W; Song B; Wang Y; Yan L; Wu F; Zhang R; Mao Y; Wang Z
J Comput Assist Tomogr; 2023 Mar-Apr 01; 47(2):199-204. PubMed ID: 36790871
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics.
Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X
J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461
[TBL] [Abstract][Full Text] [Related]
16. Prediction of neoadjuvant chemotherapy pathological complete response for breast cancer based on radiomics nomogram of intratumoral and derived tissue.
Zheng G; Hou J; Shu Z; Peng J; Han L; Yuan Z; He X; Gong X
BMC Med Imaging; 2024 Jan; 24(1):22. PubMed ID: 38245712
[TBL] [Abstract][Full Text] [Related]
17. Mammography-based radiomics nomogram: a potential biomarker to predict axillary lymph node metastasis in breast cancer.
Tan H; Wu Y; Bao F; Zhou J; Wan J; Tian J; Lin Y; Wang M
Br J Radiol; 2020 Jul; 93(1111):20191019. PubMed ID: 32401540
[TBL] [Abstract][Full Text] [Related]
18. A Novel Combined Nomogram Model for Predicting the Pathological Complete Response to Neoadjuvant Chemotherapy in Invasive Breast Carcinoma of No Specific Type: Real-World Study.
Zhu X; Shen J; Zhang H; Wang X; Zhang H; Yu J; Zhang Q; Song D; Guo L; Zhang D; Zhu R; Wu J
Front Oncol; 2022; 12():916526. PubMed ID: 35734603
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging radiomics analysis based on intratumoral subregions for predicting luminal and nonluminal breast cancer.
Feng S; Yin J
Quant Imaging Med Surg; 2023 Oct; 13(10):6735-6749. PubMed ID: 37869317
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound radiomics-based nomogram to predict lymphovascular invasion in invasive breast cancer: a multicenter, retrospective study.
Du Y; Cai M; Zha H; Chen B; Gu J; Zhang M; Liu W; Liu X; Liu X; Zong M; Li C
Eur Radiol; 2024 Jan; 34(1):136-148. PubMed ID: 37518678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]